Bordetella bronchiseptica infects a wide variety of mammals, and the type III secretion system (T3SS) is involved in the long-term colonization by Bordetella in the trachea and lung. T3SS translocates virulence factors (commonly referred to as effectors) into host cells, leading to alterations in the host's physiological function. The Bordetella effectors BopN and BteA are known to have roles in up-regulation of IL-10 and cytotoxicity, respectively. Nevertheless, the mechanism by which BopN is translocated into host cells has not been examined in sufficient detail. Therefore, to determine the precise mechanisms of the BopN translocation into host cells, we built truncated derivatives of BopN and evaluated the derivatives' ability to translocation into host cells by adenylate cyclase-mediated translocation assay. It was found that N-terminal amino acid (aa) residues 1-200 of BopN are sufficient for its translocation into host cells. Interestingly, BopN translocation was completely blocked by deletion of the N-terminal aa residues 6-50, indicating that the N-terminal region is critical for BopN translocation. Furthermore, BopN appears to play an auxiliary role in BteA-mediated cytotoxicity. Thus, BopN can apparently translocate into host cells and may facilitate activity of BteA.
BteA, which triggers cytotoxicity in a wide variety of cultured cell lines (10, 11) , is translocated into the host cells via 48 aa residues at its N-terminal. We reported in 2012 that BspR acts as a transcriptional regulator that positively and negatively regulates various virulence and non-virulence genes (7) . More recently, we observed that BspR is translocated into the nuclei of infected cells (6) . Although the BspR's precise function in host cells remains unclear, this molecule functions as a multifunctional effector in both bacteria and host cells. BopN shows sequence similarity to Yersinia YopN, which regulates T3SS activity (14) . Therefore, BopN is thought to be a regulator of the T3SS. In a previous study, we demonstrated that BopN is involved in up-regulation of the anti-inflammatory cytokine IL-10, leading to immune evasion of infected niches (8) . However, the characteristics of BopN translocation and its function within infected cells remain to be elucidated.
To further analyze BopN translocation into infected host cells, we constructed truncated derivatives of BopN and investigated their translocation by means of an adenylate cyclase-mediated translocation assay. In addition, we evaluated the auxiliary effect of BopN on BteA-mediated cytotoxicity by an LDH-release assay.
MATERIALS AND METHODS

Growth media and bacterial strains
We used the wild-type strain B. bronchiseptica S798 in this study (13) . We derived strain DT3SS, which is a type III isogenic secretion mutant (13) , and a double mutant of BteA and CyaA (DBteA DCyaA) (6) from the S798 strain. We used Escherichia coli DH10 (Invitrogen, Carlsbad, CA, USA) for DNA cloning and plasmid preparation. We prepared an inoculum of the Bordetella strain from fresh colonies grown on Bordet and Gengou agar, as described elsewhere (15), and we cultured the inoculum in Stainer and Scholte medium (16) . The starting A 600 was 0.2 and the culture was subjected to vigorous shaking (120 oscillation/min) at 37°C. For both the infection assays and protein preparation experiments, an 18 hr liquid cultivation period was used. We inoculated the Escherichia coli strains in lysogeny broth and subjected them to 16 hr incubation at 37°C with continuous shaking.
Cell culture
We maintained L2 (ATCC CCL-149) cells in F-12K (Gibco, Carlsbad, CA, USA) with 10% FCS. Table 1 lists the primers used and Table 2 the plasmids used.
Primers and plasmids
Construction of the plasmids used for producing BopN-and BteA-CyaA fusion proteins
We performed a PCR to amplify a 1.2 kbp fragment encoding bopN and used B1-bopN-FL and 3-IF-bopN primers and S798 genomic DNA as a template. We amplified the DNA fragment encoding the AC domain (i.e., the N-terminal 400 aa residues) of B. pertussis CyaA using 5-cyaA-gs and B2-cyaA primers and pMS109 (17) as the template. We used In-Fusion enzyme (Clontech, Mountain View, CA, USA) to ligate the bopN and cyaA fragments together, after which we used the adaptor PCR method with the Gateway cloning system (Thermo Fisher Scientific, Wilmington, DE, USA) to add attB1 and attB2 recognition sites to the 5' and 3' flanking sites of the bopN-cyaA fused gene, respectively. To obtain pDONR-BopN-FL-AC by BP reaction, we cloned the resulting bopN-cyaA into pDONR201 in the Gateway cloning system.
To allow expression of bopN-cyaA fusion gene under the control of the fha promoter and rrnB terminator, we mixed pDONR-fhaP, pDONR-BopN-FL-AC, pDONR-rrnB, and the Bordetella vector pRK415 R4-R3-F and then treated the resultant mixture with LR Clonase II Plus (Thermo Fisher Scientific) to clone the fha promoter, bopN-cyaA gene and rrnB terminator into pRK415 R4-R3-F. We used the MultiSite Gateway system (Thermo Fisher Scientific)and designated the resulting plasmid "pRK-BopN-FL". To create plasmids that encode truncated versions of BopN fused with CyaA, we performed an inverse PCR with the primers IF-bopN-51-365-L3 and IF-bopN-51-365-U3 (using circular pDONR201-BopN-FL-AC as a template) to obtain pDONR-BopN-D6-50-AC (N-terminal 6-50 aa deletion of BopN fused with AC domain). Using the same experimental procedure, we also constructed pDONR-BopN-D6 Plasmid containing cyaA 17 pDONR-fhaP fha promoter region cloned into pDONR201 10 pDONR-rrnB rrnB terminator region cloned into pDONR201 10 pRK415 R4-R3-F Expression vector for Bordetella We also constructed an expression vector for production of the N-terminal 48 aa residues of BteA fused with AC as a positive control, since this effector has an ability to translocate into the host cell via its Nterminal 48 aa residues (10) . With a PCR and using S798 genomic DNA, we amplified a 2.0 kbp fragment encoding bteA with the B1-bteA-comp and 3-bteA-gs primers. We subsequently added DNA linker for cyaA to the resulting bteA fragment by a PCR using B1-bteAcomp and 3-gs-cyaA. Using pMS109 and the primers B2-cyaA and 5-cyaA-gs, we amplified a DNA fragment encoding cyaA. We then ligated the bteA and adenylate cyclase gene fragments together by performing a combination PCR using B1-bteA-comp and B2-cyaA primers and cloned the resulting bteA-cyaA into pDONR221 to get pDONR-BteA-FL-AC by a BP reaction. Next, we performed an inverse PCR with the primers KpnI-gs-cyaA and p74-48 aa-bla-KpnI and with circular pDONR-BteA-FL-AC as a template to create plasmids encoding truncated versions of BteA fused with AC, in order to obtain pDONR-BteA-48-AC. Using the same experimental procedure, we also constructed pDONR-BteA-4-AC, with the primers KpnI-gs-cyaA and p74-4aa-bla-KpnI. We mixed pDONR-BteA-48-AC and pDONR-BteA-4-AC with pDONR-fhaP, pDONRrrnB and pRK415 R4-R3-F in the presence of LR Clonase II Plus, using the MultiSite Gateway system, to get pRKBteA-48 and pRK-BteA-4, respectively.
Preparation of proteins from whole bacterial cells and bacterial culture supernatants
We prepared the whole bacterial cell lysates and proteins secreted into the culture supernatants by trichloroacetic acid precipitation, as described previously (10), then resuspended the resultant bacterial pellets in distilled water and filtered the culture supernatants. We then added trichloroacetic acid at a final concentration of 10% to each sample. After a 15 min incubation on ice, we subjected the protein samples to a 5 min centrifugation. We then neutralized the precipitated proteins that we had thus obtained with 2 M Tris-base and dissolved them in sample buffer to undergo SDS-PAGE.
Antibodies and immunoblot analysis
Anti-BteA antibodies have been described elsewhere (10). We purchased anti-CyaA antibodies from Santa Cruz Biotechnology (Santa Cruz, CA, USA). We used HRP-conjugated Protein A (GE Healthcare, Piscataway, NJ, USA) and anti-mouse IgG (Sigma-Aldrich, St Louis, MO, USA) as the secondary antibodies.
For immunoblot analysis, we performed SDS-PAGE to separate protein samples and then transferred them to polyvinylidene difluoride membranes (Immobilon filter; Millipore, Bedford, MA, USA). To detect the proteins on the membrane, we performed immunoblotting using the digital imaging system ImageQuant LAS 4000 (GE Healthcare) and the substrate Luminata Forte Western HRP (Millipore).
LDH assays
To evaluate the release of LDH from infected cells, we infected 5.0 Â 10 4 L2 cells seeded in 24-well plates with bacteria at a MOI of 50, as described elsewhere (10) . We then centrifuged the cells for 5 min at 1700 rpm and incubated them at 37°C in an atmosphere of 5% CO 2 for 1 hr. We used spectrophotometry to measure the amount of LDH using a CytoTox 96 Non-Radioactive Cytotoxicity Assay kit (Promega, Madison, WI, USA). We calculated the relative amount of LDH release (%) using the following equation: experimental LDH activity/total LDH activity Â 100. We measured total LDH activity using cells that we had treated with 1% Triton X-100.
Adenylate cyclase-based translocation assay
When BopN-AC fusion protein is delivered into host cells via the T3SS, AC is activated by interaction with cytosolic calmodulin, resulting in an increased amounts of cAMP (18) . We used a cAMP enzyme immunoassay (Amersham cAMP Biotrak Enzyme Immunoassay System; GE Healthcare Life Sciences) to measure translocation of the AC fusion protein into the host cytosol. We infected L2 cells (4 Â 10 4 cells/well) seeded in 24-well plates with Bordetella strains at an MOI of 20 for 1 hr. After infection, we lysed and treated the cells according to the manufacturer's instructions.
RESULTS
The N-terminal region of BopN is involved in translocation into host cells
In a previous study, we showed that BopN is translocated into the nucleus and is involved in up-regulation of IL-10 (8). However, the detailed mechanism by which BopN is translocated into host cells remains to be elucidated. To determine whether BopN is translocated into host cells via the T3SS, we generated expression vectors encoding full-length BopN or its truncated derivatives fused with the AC domain of CyaA (Fig. 1) and introduced them into the B. bronchiseptica DBteA DCyaA strain, which lacks host cell cytotoxicity activity by BteA and endogenous AC activity. In addition, we used pRK-BteA-48 as a positive control, having previously demonstrated that the N-terminal 48 aa residues of BteA are sufficient for its translocation into host cells in a T3SS-dependent manner (10) .
To confirm production of the BopN-AC fusion protein in B. bronchiseptica strains, we separated the secreted proteins by SDS-PAGE and examined them by CBB staining (Fig. 2, upper panel) . We detected type III secreted proteins, BopN, BopD and Bsp22 in the S798 DBteA DCyaA strain with or without the plasmids. We also performed an immunoblotting analysis using antiCyaA antibodies and detected specific signals of BopN-AC fusion proteins in the culture supernatants and whole bacterial cell lysates (Fig. 2 , middle and lower panels). We detected the signals specific for each of the BopN-AC fusion proteins in the bacterial culture supernatants, but did not detect signals of BopN-AC fusion protein (pRK-BopN-FL) in the culture supernatant sample prepared from the DT3SS strain (Fig. S1) . These results clearly indicate that BopN-AC fusion proteins are secreted via the T3SS into culture supernatants.
To evaluate BopN's ability to translocate into host cells, we infected L2 cells with B. bronchiseptica DBteA DCyaA strains producing BopN-AC fusion derivatives, and examined the ability of BopN-AC to translocate into L2 cells by using an adenylate cyclase-based translocation assay. As expected, we detected high concentrations of cAMP in the L2 cell lysates that we had infected with DBteA DCyaA strains carrying pRK-BteA-48, which produces the N-terminal 48 aa residues of BteA fused with AC (Fig. 3) . We also observed large amounts of cAMP in the DBteA DCyaA strains carrying pRK-BopN-FL, pRK-BopN-D6-10, pRK-BopN-D11-50 and pRKBopN-200 (Fig. 3) . However, we did not detect cAMP in the DBteA DCyaA strain carrying pRK-BopN-D6-50, pRK-BopN-50 and pRK-BopN-20. Taken together, these findings demonstrate that the translocation signal of BopN is located in the N-terminal 200 aa residues and that the N-terminal aa residues 6-50 are critical for T3SS-mediated translocation into host cells.
BteA-mediated cytotoxicity is fully activated by BopN
In a previous study, we found by introduction of the BteA-expression vector into HeLa cells that BteA alone is sufficient for induction of cytotoxicity (10) . To further investigate BteA-mediated cytotoxicity during Bordetella infection, we infected L2 cells with wild-type B. bronchiseptica, DBteA, DBopN and BopNcomplemented (DBopN/pBopN) strains and measured release of LDH into the extracellular medium as described in the Materials and Methods section. As expected, much less LDH was released after infection of L2 cells with the DBteA strain than after infection of L2 cells with the wild-type B. bronchiseptica strain (Fig. 4) . Interestingly, the amount of LDH release was also reduced in infection of L2 cells with the DBopN strain and restored in the BopN-complemented strain (Fig. 4 ). We confirmed that the level of type III secreted proteins in the culture supernatant was not affected by the BopN disruption (Fig. 5) . Again, both the production and secretion profiles of BteA in the BopN mutant were similar to those of the wild-type strain (Fig. 6) . Thus, BopN mutation did not affect BteA production and secretion into the culture supernatant. Collectively, these results suggest that BopN plays an auxiliary role by enhancing the activity of the BteA-mediated cytotoxicity.
DISCUSSION
The results of the present investigation demonstrate that BopN is translocated into host cells via the T3SS and that the N-terminal region is essential for 3SS-mediated translocation into host cells. We also observed that the BteA-mediated cytotoxicity is facilitated by BopN.
The machinery of the T3SS is highly conserved among Gram-negative pathogens and its function is interchangeable between some Gram-negative bacteria. For example, a Bordetella type III secreted protein, BspR, is The data for each sample are presented as mean AE SE of three independent experiments. ÃÃ , P < 0.01. WT, wild-type.
secreted and translocated into host cells via the T3SS of enteropathogenic E. coli (6) . Although the machinery of T3SS has functional similarity among different pathogens, the characteristics of the secretion and translocation signals recognized by the T3SS are not highly conserved and can be roughly divided into two categories. In the case of the enteropathogenic E. coli effectors Map, EspF and Tir, the signals for type III mediated-secretion and Àtranslocation into the host cells are included in the N-terminal 20 aa residues (19) .
In contrast, secretion and translocation signals are not located in the same region in Yersinia species. For example, the type III-mediated secretion signal of the Yersinia effector YopE is located in the N-terminal 15 aa residues (20) . However, the N-terminal 50 aa residues are required for YopE translocation into host cells (20) . Yersinia effector YopH has a similar phenotype (20) . In B. bronchiseptica, BteA, BspR and BopN are secreted into the bacterial culture supernatants. In this study, we showed that the translocation signal of BopN is located within the N-terminal region (residues 1-200). Although the stability of BopN produced from pRK-BopN-20 was greatly reduced, the BopN truncated derivative was secreted in the bacterial culture supernatant (Fig. 2) As Figure 7 shows, BopN shows 55.0% and 59.1% amino acid sequence similarity with Yersinia enterocolitica YopN and TyeA, respectively. YopN is involved in a regulatory mechanism for the Yersinia T3SS together with TyeA, which binds to the C-terminal half of YopN and functions as a negative regulator for YopN secretion (21) . Deletion of YopN reportedly results in a constitutive secretion phenotype of Yersinia effectors and in loss of polarized translocation after cell contact (21) . BopN appears to be a chimeric product of YopN and TyeA. Indeed, a genetically engineered frameshifted YopN-TyeA hybrid maintains the regulatory control of Yop proteins in Yersinia, in vitro (22) .
We recently revealed that wild-type B. bronchiseptica induces antiphagocytic activity and localizes to extracellular surfaces of the mouse dendritic cell line DC2.4 (23) . In contrast, phagocytosed bacteria have been detected in DC2.4 cells infected with DBteA (23). Although the relationship between cytotoxicity and phagocytosis inhibition remains to be characterized, BteA is involved in inhibition of phagocytosis by DC2.4 cells. In a previous study, we found that the level of cytotoxic activity in DC2.4 cells infected with B. bronchiseptica wild-type strain is similar to that in DC2.4 cells infected with DBopN strain. However, it remains unclear whether the cytotoxic activity of BopN differs between dendritic and epithelial cells. On the basis of these findings, we propose the following working hypothesis for BopN function: (i) BopN regulates translocation of BteA in host cells; and (ii) BopN activates BteA function in host cells.
It is fascinating that BopN facilitates BteA-mediated antiphagocytosis activity and that the resulting surfacelocalized Bordetella can inject effectors into DCs or macrophages. BopN has multiple biological activities, including induction of an anti-inflammatory cytokine, IL-10, and down regulation of mitogen-activated protein kinase during infection with DC2.4 cells (8) . Thus, synergistic effects of BopN and BteA may be involved in their stealth strategy for shutting off the host inflammatory reaction by exploiting the function of DCs.
